Risk of Tuberculosis Infection and Tuberculous Meningitis after Discontinuation of Bacillus Calmette–Guerin in Beijing
- 1 October 2000
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 162 (4), 1314-1317
- https://doi.org/10.1164/ajrccm.162.4.9911106
Abstract
In Beijing, the notification rate of smear-positive tuberculosis (TB) has been below 20 per 100,000 since 1986, and continues to decline. To accurately measure the risk of TB infection in a population in which the results of tuberculin skin testing were not confounded by vaccination with Bacillus Calmette-Guerin (BCG), BCG vaccination at birth was discontinued from 1988 in Shun-yi County. In 1995, the prevalence of TB infection among 12,836 primary school children aged 6 to 7 yr and without BCG scars was 1.4%, giving an estimated annual risk of infection of 0.19% (95% confidence interval: 0.16 to 0.22%). The prevalence of TB infection in children aged 5 to 9 yr in Beijing in 1950 was 46%. The number of cases of tuberculous meningitis did not increase after discontinuation of BCG. We conclude that discontinuation of BCG had no detectable harmful effects, and that control of TB in Beijing has markedly reduced the prevalence of TB infection since 1950.Keywords
This publication has 9 references indexed in Scilit:
- Comparative Genomics of BCG Vaccines by Whole-Genome DNA MicroarrayScience, 1999
- Vaccines, Genes and TrialsPublished by Wiley ,1998
- Guidelines for conducting tuberculin skin test surveys in high prevalence countriesTubercle and Lung Disease, 1996
- Methodological issues in the estimation of the tuberculosis problem from tuberculin surveysTubercle and Lung Disease, 1995
- Delayed-type hypersensitivity, mycobacterial vaccines and protective immunityThe Lancet, 1994
- Criteria for discontinuation of vaccination programmes using bacille calmette-guerin (BCG) in countries with a low prevalence of tuberculosisTubercle and Lung Disease, 1994
- Tuberculosis control programme in BeijingTubercle and Lung Disease, 1992
- Efficacy of BCG vaccine against leprosy and tuberculosis in northern MalawiThe Lancet, 1992
- Impact of BCG vaccination programmes in children and young adults on the tuberculosis problemTubercle, 1976